Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
about
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.Role of vaccine therapy for renal cell carcinoma in the era of targeted therapyInhibitory effects of progesterone differ in dendritic cells from female and male rodents.Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.Dendritic cell vaccine strategies for renal cell carcinoma.Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer.Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease.Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches.Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.A novel murine model of allogeneic vaccination against renal cancer.
P2860
Q24814644-D43ADDDA-4360-4399-9B62-787D2DB47A59Q27016032-82321BC6-01D5-4AAB-BBEC-82EFC32C6E02Q34137092-81D297D6-3FB1-4136-8BB2-E2BD44B1E897Q34443707-373D88A6-19A2-4154-AD49-7C9480818DB8Q35765914-ED74B928-897E-4004-B5EC-9029835B9ECCQ36717351-3399410D-F520-4910-9E66-F2CBB7ACA92BQ36736462-A97E39C6-8033-41A1-A950-60F872F42FECQ37765583-3BC9FC6B-9C53-4874-B0B6-7DB029034E2CQ37863518-D4E97E9D-6ABD-4942-B0F0-E1DB9E907236Q37892594-7857290C-AA5A-45DC-90E6-F99F6C62334FQ38099023-0E75AC4A-F211-4EB0-86E2-6B3AD9EBB87BQ39633315-AE2D011D-B932-4F5E-9CC1-F36D065E147BQ39993662-9A422BF8-6BF2-495F-BD34-F925CADB8B49
P2860
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@ast
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@en
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@nl
type
label
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@ast
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@en
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@nl
prefLabel
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@ast
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@en
Cell-based vaccines for renal ...... ocyte-derived dendritic cells.
@nl
P2093
P1476
Cell-based vaccines for renal ...... nocyte-derived dendritic cells
@en
P2093
Antonio Pezzutto
Bernhard Frankenberger
Christiane Geiger
Christine S Falk
Dolores J Schendel
Elfriede Noessner
Gerald Willimsky
Heike Pohla
Michael Siebels
Miran Javorovic
P2888
P304
P356
10.1007/S00345-005-0505-5
P577
2005-07-05T00:00:00Z
P6179
1042828838